Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells

Cancer Research

Volumn 63, Issue 10, 2003, Pages 2631-2637

  Barnes, George L ^a   Javed, Amjad ^b   Waller, Sylvan M ^a   Kamal, Mohammad H ^a   Hebert, Kerri E ^a   Hassan, Mohammad Q ^b   Bellahcene, Akeila ^c   Van Wijnen, Andre J ^b   Young, Marian F ^d   Lian, Jane B ^b   Stein, Gary S ^b   Gerstenfeld, Louis C ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SIALOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ARTICLE; BONE METASTASIS; BREAST CANCER; BREAST METASTASIS; CANCER CELL CULTURE; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

BREAST NEOPLASMS; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CORE BINDING FACTOR ALPHA SUBUNITS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); SIALOGLYCOPROTEINS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0037843323     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Bellahcene, A., and Castronovo, V. Expression of bone matrix proteins in human breast cancer: potential roles in microcalcification formation and in the genesis of bone metastases. Bull Cancer, 84: 17-24, 1997.
2. Bellahcene, A., Menard, S., Bufalino, R., Moreau, L., and Castronovo, V. Expression of bone sialoprotein in primary human breast cancer is associated with poor survival. Int. J. Cancer, 69: 350-353, 1996.
3. Bellahcene, A., Antoine, N., Clausse, N., et al. Detection of bone sialoprotein in human breast cancer tissue and cell lines at both protein and messenger ribonucleic acid levels. Lab. Investig., 75: 203-210, 1996.
4. Bellahcene, A., Kroll, M., Liebens, F., and Castronovo, V. Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development. J. Bone Miner. Res., 11: 665-670, 1996.
5. Bellahcene, A., and Castronovo, V. Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Am. J. Pathol., 146: 95-100, 1995.
6. Bellahcene, A., Merville, M. P., and Castronovo, V. Expression of bone sialoprotein, a bone matrix protein, in human breast cancer. Cancer Res., 54: 2823-2826, 1994.
7. Waltregny, D., Bellahcene, A., de Leval, X., Florkin, B., Weidle, U., and Castronovo, V. Increased expression of bone sialoprotein in bone metastases compared to visceral metastases in human breast and prostate cancers. J. Bone Miner. Res., 15: 834-843, 2000.
8. Bellahcene. A., Maloujahmoum, N., Fisher, L. W., et al. Expression of bone sialoprotein in human lung cancer. Calcif. Tissue Int., 61: 183-188, 1997.
9. Waltregny, D., Bellahcene, A. Van Riet, I., Fisher, L. W., Young, M., Fernandez, P., Dewe, W., de Leval, J., and Castronovo, V. Prognostic value of bone sialopotein expression in clinically localized human prostate cancer. J. Natl. Cancer Inst. (Bethesda), 90: 1000-1008, 1998.
10. Fedarko, N., Fohr, B., Robey, P., Young, M., and Fisher. L. Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack. J. Biol. Chem., 275: 16666-16672, 2000.
11. Bellahcene, A., Bonjean, K., Fohr, B. Fedarko, N., Robet, F., Young, M., Fisher, L., and Castronovo, V. Bone sialoprotein mediates human endothelial cell attachment and migration and promotes angiogenesis. Circ. Res., 86: 885-891, 2000.
12. Banerjee, C., McCabe, L. R., Choi, J. Y., Hiebert, S. W., Stein, J. L., Stein, G. S., and Lian, J. B. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J. Cell. Biochem., 66: 1-8, 1997.
13. Benson, M. D., Bargeon, J. L., Xiao, G., Thomas, P. E., Kim, A, Cui, Y., and Franceschi, R. T. Identification of a homeodomain binding element in the bone sialoprotein promoter that is required for its osteoblast-selective expression. J. Biol. Chem., 275: 13907-13917, 2000.
14. Dodig, M., Tadic, T., Kronenberg, M. S., Dacic, S., Liu, Y. H., Maxson, R., Rowe, D. W., and Lichtler, A. C. Ectopic Msx-2 overexpression inhibits and Msx-2 antisense stimulates calvarial osteoblast differentiation. Dev. Biol., 209: 298-307, 1999.
15. Javed, A., Barnes, G., Jasanya, B., Stein, J., Gerstenfeld, L., Lian, J., and Stein, G. The runti homology domain transcription factors mediate repression of the bone sialoprotein promoter: evidence for a context dependent activity of Cbfa proteins. Mol. Cell. Biol., 8: 891-905, 2001.
16. Miyama, K., Yamada, G., Yamamoto, T. S., Takagi, C., Miyado, K., Sakai, M., Ueno, N., and Shibuya, H. A BMP-inducible gene, Dlx-5, regulates osteoblast differentiation and mesoderm induction. Dev. Biol., 208: 123-133, 1999.
17. Newberry, E. P., Latifi, T., and Towler, D. A. Reciprocal regulation of osteocalcin transcription by the homeodomain proteins Msx2 and Dlx5. Biochemistry, 37: 16360-16368, 1998.
18. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., and Karsenty, G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation [see comments]. Cell, 89: 747-754, 1997.
19. Phippard, D. J., Weber-Hall, S. J., Sharpe, P. T., Naylor, M. S., Jayatalake, H., Maas, R., et al. Regulation of Msx-1, Msx-2, Bmp-2 and Bmp-4 during fetal and postnatal mammary gland development. Development, 122: 2729-2737, 1996.
20. Baxter, E. W., Blyth, K., Cameron, E. R., and Neil, J. C. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Maloney murine leukemia virus infection in myc transgenic mice. J. Virol., 75: 9790-9798, 2001.
21. Blyth, K., Terry, A., Mackay, N., Vaillant, F., Bell, M., Cameron, E. R., Neil, J. C., and Stewart, M. Runx2: a novel oncogenic effector revealed by in vivo complementation and retroviral tagging. Oncogene, 20: 295-302, 2001.
22. Cohen, M. M., Jr. RUNX genes, neoplasia, and cleidocranial dysplasia. Am. J. Med. Genet., 104: 185-188, 2001.
23. Thompson, E. W., Sung, V., Lavigne, M., Baumann, K., Azumi, N., Aaron, A. D., and Clark, R. LCC15-MB: a vimentin-positive human breast cancer cell line from a femoral bone metastasis. Clin. Exp. Metastasis, 17: 193-204, 1999.
24. Barnes, G. L., Della Torre, T., Sommer, B., Young, M. F., and Gerstenfeld, L. C. Transcriptional regulation restricting bone sialoprotein gene expression to both hypertrophic chondrocytes and osteoblasts. J. Cell. Biochem., 87: 458-469, 2002.
25. Harada, H., Tagashira, S., Fujiwara, M., Ogawa, S., Katsumata, T., Yamaguchi, A., Komori, T., and Nakatsuka, M. Cbfa1 Isoforms exert functional differences in osteoblast differentiation. J. Biol. Chem., 274: 6972-6978, 1999.
26. Xiao, Z. S., Thomas, R., Hinson, T. K., and Quarles, L. D. Genomic structure and isoform expression of the mouse, rat, and human Cbfa1/Osf2 transcription factor. Gene (Amst.), 214: 187-197, 1998.
27. Stewart, M., Terry, A., Hu, M., O'Hara, M., Blyth, K., Baxter, E., Cameron, E., Onions, D. E., and Neil, J. C. Proviral insertions induce the expression of bone-specific isoforms of PEBP2αA (CBFA1): evidence for a new myc collaborating oncogene. Proc. Natl. Acad. Sci. USA, 94: 8646-8651, 1997.
28. Vaillant, F., Blyth, K., Terry, A., Bell, M., Cameron, E. R., Neil, J., and Stewart, M. A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc. Oncogene, 18: 7124-7134, 1999.
29. Acampora, D., Merlo, G. R., Paleari, L., Zerega, B., Postiglione, M. P., Mantero, S., Bober, E., Barbieri, O., Simeone, A., and Levi, G. Craniofacial, vestibular and bone defects in mice lacking distal-less-related gene Dlx-5. Development, 126: 3795-3809, 1999.
30. Barnes, G. L., Hebert, K. E., Hassan, M. Q., van Wijen, A., Young, M. F., Lian, L. B., Stein, G. S., and Gerstenfeld, L. C. Regulation of bone sialoprotein gene expression by the homeodomain proteins Msx2 and Dlx5. American Society of Bone and Mineral Research 24th annual meeting, 2002.
31. Bellahcene, A., Albert, V., Pollina, F., Basolo, F., Fisher, L. W., and Castronovo, V. Ectopic expression of bone sialoprotein in human thyroid cancers. Thyroid, 8: 637-641, 1998.
32. Komori, T., Yagi, H., Nomura, S., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell, 89: 755-764, 1997.
33. Hess, J., Porte, D., Munz, C., and Angel, P. AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast specific element 2/AP-1 composite element. J. Biol. Chem., 276: 20029-20038, 2001.
34. Zelzer, E., Glotzer, D. J., Hartmann, C., Thomas, D., Fukai, N., Soker, S., and Olsen, B. R. Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech. Dev., 106: 97-106, 2001.
35. Barrett, J. M., Puglia, M. A., Singh, G., and Tozer, R. G. Expression of Ets-related transcription factors and matrix metalloproteinase genes in human breast cancer cells. Breast Cancer Res. Treat., 72: 227-232, 2002.
36. Guise, T. A., Yin, J. J., Thomas, R. J., Dallas, M., Cui, Y., and Gillespie, M. T. Parathyroid hormone-related protein (PTHrP)-(1-139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo. Bone (N. Y.), 30: 670-676, 2002.
37. Guise, T. A. Parathyroid hormone-related protein and bone metastases. Cancer (Phila.), 80 (8 Suppl.): 1572-1580, 1997.
38. Liu, J. F., Crepin, M., Liu, J. M., Barritault, D., and Ledoux, D. FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochem. Biophys. Res. Commun., 293: 1174-1182, 2002.
39. Sung, V., Gilles, C., Murray, A., et al. The LCC15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype. Exp. Cell Res., 241: 273-284, 1998.
40. Thomas, R. J., Guise, T. A., Yin, J. J., Elliott, J., Horwood, N. J., Martin, T. J., and Gillespie, M. T. Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology, 140: 4451-4458, 1999.
41. Winding, B., NicAmhlaoibh, R., Misander, H., Hoegh-Andersen, P., Andersen, T. L., Holst-Hansen, C., Heegaard, A. M., Foged, N. T., Brunner, N., and Delaisse, J. M. Synthetic matrix metalloproteinase inhibitors inhibit growth of established breast cancer osteolytic lesions and prolong survival in mice. Clin. Cancer Res., 8: 1932-1939, 2002.
42. Yin, J. J., Selander, K., Chirgwin, J. M., Dallas, M., Grubbs, B. G., Wieser, R., Massague, J., Mundy, G. R., and Guise, T. A. TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J. Clin. Investig., 103: 197-206, 1999.
43. Meyers, S., Lenny, N., and Hiebert, S. W. The t(8:21) fusion protein interferes with ami-1b-dependent transcriptional activation. Mol. Cell. Biol., 15: 1974-1982, 1995.
44. Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., and Kaneko, Y. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, amll. Proc. Natl. Sci. USA., 88: 10431-10434, 1991.
45. Look, A. T. Oncogenic transcription factors in the human acute leukemias. Science (Wash. DC), 278: 1059-1064, 1997.
46. Yeung, F., Law, W. K., Yeh, C. H., Westendorf, J. J., Zhang, Y., Wang, R., Kan, C., and Chang, L. W. K. Regulation of human osteocalcin promoter in hormone-independent human prostate cancer cells. J. Biol. Chem., 277: 2468-2476, 2002.